Novel Diagnostic Test for EU BSE-Surveillance Program
ZURICH, Switzerland, March 14 /PRNewswire/ -- The Scientific Steering Committee of the European Commission today recommended the novel Prionics(R)-Check LIA BSE-Test for the EU Surveillance Program. "With our new BSE test, we are comprehensively equipped to meet future market needs today," says Dr. Bruno Oesch, CEO and Head of Research & Development at Prionics. The Prionics(R)-Check LIA is the first rapid BSE test that is easy to use both manually and when integrated into a fully automated system. The LIA was designed to complement the most successful BSE test worldwide, the Prionics(R)-Check WESTERN, which has established itself among BSE experts as the reference for BSE rapid tests, due to its unmatched precision and reliability. "The two tests form an ideal and 100 per cent reliable complementary testing system able to meet the most diverse needs of our customers," explains Prionics' Marketing Director, Karl Kalf. The Prionics(R)-Check LIA was evaluated by the European Commission in a field study carried out by BSE experts at two different national BSE reference centers and four routine diagnostic laboratories. The large-scale study was the first of its kind. It focused not only on the technical specifications of the novel BSE test but also on its precision in field use, particularly under adverse conditions. The Prionics(R)-Check LIA not only fulfilled all requirements it also demonstrated 100 per cent sensitivity, underlining its suitability for reliable detection of BSE animals. The test also exhibited 100 per cent specificity, which means that it would not incorrectly identify samples from healthy animals as BSE positive. "The results of the EU study prove that the test is unbeatable in sensitivity and specificity," says Kalf. "Absolute reliability and high precision under field conditions represent the ambitious and demanding criteria which must be met by any new test developed by Prionics. Each individual result is important in consumer protection, especially as substances derived from one single cow can reach between 200,000 and 400,000 (1) consumers." About Prionics: Prionics AG is the world leader in the early diagnosis of prion diseases such as Bovine Spongiform Encephalopathy ("Mad Cow disease") and scrapie. The company shot to fame in 2000 when its BSE tests uncovered the devastating fact that cattle across Europe had contracted Mad Cow disease. Prionics' research and development efforts are focused on neurological and prion diseases. The Prionics research team works closely with a network of prion and neurological experts around the world, and the company is now considered an international center of excellence in the diagnosis of prion diseases. Prionics AG is a ISO 9001 certified company and currently employs 80 people. Reference: 1. Opinion of the Scientific Steering Committee on the Human Exposure Risk (HER) via food with respect to BSE -- Adopted on 10 December 1999; http://europa.eu.int/comm/food/fs/sc/ssc/out67_en.pdf
SOURCE Prionics AG
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.